OpenAlex
PricingAboutJobs
Log inGet started
Work

Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer’s Disease and Other Neurodegenerative Diseases

HTML

Year: 2015
Type: review
Source: CNS Drugs
DOI: 10.1007/s40263-015-0301-8
Authors: Valeria Calsolaro, Paul Edison
Institutions: Hammersmith Hospital, Imperial College London
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: glucagon-like peptide-1, GLP-1 receptor, GLP-1 analogues, insulin signaling, Alzheimer's disease, Parkinson's disease, neurodegenerative diseases, diabetes mellitus, liraglutide, exenatide, lixisenatide, cognitive function, preclinical drug development
SDG: Good health and well-being

Open Access status: closed

Funders: Alzheimer's Drug Discovery Foundation, Alzheimer's Society, Alzheimer’s Research UK, Novo Nordisk, GE Healthcare, Medical Research Council
OpenAlex ID: W2221406620
FWCI: 0.786
Cites: 107
Cited by: 99
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security